Medtronic Faces False Marking Suit Over Stents

By James Armstrong

Law360, New York (July 12, 2010, 4:30 PM ET) -- Promote Innovation LLC has accused Medtronic Inc. of falsely marking its stents with patents found unenforceable due to inequitable conduct.

Medtronic had no right to mark its Endeavor stent system and other products with two patents declared unenforceable in court, according to a qui tam suit Promote Innovation filed Friday in the U.S. District Court for the Eastern District of Texas.

Zachariah Harrington, an attorney at Antonelli Harrington & Thompson LLP who represents the plaintiff, said the patents were found to be unenforceable in 2008, and...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles